Sidra Ellis

Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

G. Morgan, R. Houlston, W. Gregory, 2020, Leukemia.

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

G. Morgan, R. Houlston, W. Gregory, 2017, Leukemia.

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

G. Morgan, A. Mead, R. Houlston, 2020, Leukemia.

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

G. Morgan, M. Greaves, W. Gregory, 2019, Haematologica.

Subclonal TP53 copy number is associated with prognosis in multiple myeloma.

G. Morgan, R. Houlston, W. Gregory, 2018, Blood.